What is BioCryst Pharmaceuticals's FX effect on cash?

BioCryst Pharmaceuticals (BCRX) reported FX effect on cash of -$72K in Q1 2026.

How has BioCryst Pharmaceuticals's FX effect on cash changed year-over-year?

BioCryst Pharmaceuticals's FX effect on cash decreased by 116.0% year-over-year, from $451K to -$72K.

What is the long-term trend for BioCryst Pharmaceuticals's FX effect on cash?

Over 2 years (2022 to 2024), BioCryst Pharmaceuticals's FX effect on cash has grown at a 27.0% compound annual growth rate (CAGR), from $580K to -$936K.

What does FX effect on cash mean?

The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.

BioCryst Pharmaceuticals BCRX FX Effect on Cash

FX Effect on Cash at other companies

Ultragenyx PharmaceuticalRARE

-$1M-200%

Arrowhead ResearchARWR

$997K+348%

ALN

Alnylam PharmaceuticalsALNY

-$7.06M-150%

PrecigenPGEN

-$3K-250%

Acadia PharmaceuticalsACAD

$25K+600%

Ionis PharmaceuticalsIONS

——

Other financials

Income statement

See full

Revenue$156.4M+7.5%

Gross profit$151.0M+7.1%

Operating income-$701.6M-3,405%

Net income-$721.8M-2,255,763%

EPS (diluted)-$2.98—

Balance sheet

See full

Cash & equivalents$173.4M+62.2%

Total debt$411.8M+24.7%

Total equity-$553.8M-22.6%

Total assets$465.1M-3.1%

Cash flow

See full

Operating cash flow-$61.8M-125%

CapEx$403.0K+182%

Free cash flow-$62.2M-125%

Valuation

See full

Market cap$2.37B+52.3%

Enterprise value$2.6B+46.7%

P/S2.7×-0.4×

Profitability

See full

Gross margin97.8%+0.8pp

Operating margin-43.1%-49.7pp

Net margin-51.7%-69.7pp

FCF margin35%—

Returns & leverage

See full

Return on equity-882.8%—

Debt / equity0.1×—

Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioCryst Pharmaceuticals's FX effect on cash?: BioCryst Pharmaceuticals (BCRX) reported FX effect on cash of -$72K in Q1 2026.
How has BioCryst Pharmaceuticals's FX effect on cash changed year-over-year?: BioCryst Pharmaceuticals's FX effect on cash decreased by 116.0% year-over-year, from $451K to -$72K.
What is the long-term trend for BioCryst Pharmaceuticals's FX effect on cash?: Over 2 years (2022 to 2024), BioCryst Pharmaceuticals's FX effect on cash has grown at a 27.0% compound annual growth rate (CAGR), from $580K to -$936K.
What does FX effect on cash mean?: The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.